These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 8378860

  • 1. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN, Shilov EM.
    Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 3. [Late results and prognosis in glomerulonephritis. II. Prognosis in specific forms of glomerulopathies].
    Hruby Z.
    Przegl Lek; 1992 Feb; 49(1-2):28-30. PubMed ID: 1455001
    [No Abstract] [Full Text] [Related]

  • 4. Steroid therapy in primary glomerulonephritis.
    Davison AM.
    Nephrol Dial Transplant; 1990 Feb; 5 Suppl 1():23-8. PubMed ID: 2129454
    [No Abstract] [Full Text] [Related]

  • 5. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM, Kallenberg CG, Stegeman CA.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract] [Full Text] [Related]

  • 6. B cell suppression in primary glomerular disease.
    Rood IM, Hofstra JM, Deegens JK, Wetzels JF.
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):166-81. PubMed ID: 24602466
    [Abstract] [Full Text] [Related]

  • 7. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N.
    Ter Arkh; 1987 Mar; 59(8):38-40. PubMed ID: 3686444
    [No Abstract] [Full Text] [Related]

  • 8. [The significance of predominant IgM deposition in glomerular diseases].
    Koshino Y, Kida H, Yokoyama H, Yoshimura M, Asamoto T, Saito Y, Tomosugi N, Abe T, Hattori N.
    Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1293-300. PubMed ID: 6527428
    [No Abstract] [Full Text] [Related]

  • 9. [Therapy of primary chronic glomerulonephritis].
    Risler T, Braun N, Erley CM.
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [Abstract] [Full Text] [Related]

  • 10. [Advances in the treatment of adult nephrotic syndrome].
    Yokoyama H, Asaka M, Yamaya H, Wada T.
    Nihon Jinzo Gakkai Shi; 2007 Dec; 49(2):108-12. PubMed ID: 17375618
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of post-transplant glomerulonephritis].
    Sandrini S, Valerio F.
    G Ital Nefrol; 2008 Dec; 25 Suppl 44():99-106. PubMed ID: 19048593
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine treatment of glomerular diseases.
    Klein M, Radhakrishnan J, Appel G.
    Annu Rev Med; 1999 Dec; 50():1-15. PubMed ID: 10073260
    [Abstract] [Full Text] [Related]

  • 13. [Immunotherapy of primary glomerulonephritis].
    Ritz E, Mickisch O.
    Internist (Berl); 1989 Mar; 30(3):180-95. PubMed ID: 2654060
    [No Abstract] [Full Text] [Related]

  • 14. Study of salivary and serum secretory IgA in IgA mesangial nephritis and primary glomerulonephritis.
    Rostoker G, Terzidis H, Petit-Phar M, Lang P, Weil B.
    Adv Exp Med Biol; 1995 Mar; 371B():835-7. PubMed ID: 7502908
    [No Abstract] [Full Text] [Related]

  • 15. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
    Cravedi P.
    G Ital Nefrol; 2012 Mar; 29(3):274-82; discussion 292. PubMed ID: 22718450
    [Abstract] [Full Text] [Related]

  • 16. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Mar; 46(10):744-9. PubMed ID: 2687950
    [No Abstract] [Full Text] [Related]

  • 17. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa, Biriukova LS, Makurov AI.
    Ter Arkh; 1992 Mar; 64(8):47-50. PubMed ID: 1440396
    [No Abstract] [Full Text] [Related]

  • 18. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C, Banfi G, Imbasciati E, Tarantino A.
    Contrib Nephrol; 1982 Mar; (34):33-54. PubMed ID: 6293765
    [No Abstract] [Full Text] [Related]

  • 19. Successful mycophenolate mofetil treatment of glomerular disease.
    Briggs WA, Choi MJ, Scheel PJ.
    Am J Kidney Dis; 1998 Feb; 31(2):213-7. PubMed ID: 9469489
    [Abstract] [Full Text] [Related]

  • 20. Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
    Manabe S, Nitta K, Nagata M.
    Contrib Nephrol; 2018 Feb; 195():131-142. PubMed ID: 29734158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.